| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 35.467 | 75.832 | 88.989 | 111.552 | 118.601 | 118.256 | 115.603 | 120.907 |
| Total Income - EUR | - | - | 35.469 | 75.968 | 89.000 | 111.569 | 118.621 | 118.277 | 115.613 | 120.918 |
| Total Expenses - EUR | - | - | 13.839 | 28.434 | 30.645 | 30.900 | 33.552 | 36.565 | 38.930 | 37.770 |
| Gross Profit/Loss - EUR | - | - | 21.630 | 47.534 | 58.355 | 80.670 | 85.069 | 81.711 | 76.683 | 83.148 |
| Net Profit/Loss - EUR | - | - | 21.277 | 46.775 | 57.465 | 79.622 | 83.907 | 80.552 | 75.550 | 79.593 |
| Employees | - | - | 2 | 4 | 3 | 3 | 3 | 3 | 3 | 3 |
Check the financial reports for the company - Cabinet Neuromedik Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 42 | 14.094 | 10.653 | 7.343 | 4.217 | 1.410 | 0 | 383 |
| Current Assets | - | - | 23.607 | 48.779 | 64.383 | 88.362 | 82.150 | 89.443 | 78.393 | 82.930 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 4.662 | 38.134 | 49.125 | 69.501 | 67.386 | 68.142 | 67.347 | 64.651 |
| Cash | - | - | 18.945 | 10.646 | 15.258 | 18.861 | 14.764 | 0 | 11.046 | 18.279 |
| Shareholders Funds | - | - | 21.320 | 46.868 | 57.516 | 79.671 | 83.955 | 80.601 | 75.599 | 79.641 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 2.329 | 16.005 | 17.520 | 16.034 | 2.412 | 10.252 | 2.795 | 3.672 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Cabinet Neuromedik Srl